BioXcel Therapeutics faces regulatory challenges after the FDA found inconsistencies in one of its clinical trial sites, jeopardizing the supplementary approval of its drug, IGALMI. BioXcel's ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. GenAI is also making a splash in software development and mobile applications. In fact, due ...

Throughput, efficiency, and reproducibility are key concerns in laboratory studies. Advances in digital science solutions and automated technologies are driving recent improvements in lab results, ...

The present world of digital transformation, streamlining workflows, enhancing operational efficiencies, and eliminating paper demands connected workflows with fully integrated systems and equipment.

Dmytro Lazarchuk is a cofounder and CEO of Relokia with over eight years of experience in digital marketing and data migration services. Annually, businesses waste $85 billion fixing technical ...

There are wide discrepancies in data quality for hotel transactions across global regions, with the largest occurring in Asia-Pacific. Because hotels and agencies need to harness data quality to ...

Australian organisations have lost an average of A$493,000 over the past 12 months due to data integrity flaws, hampering their artificial intelligence (AI) ambitions and eroding their competitive ...

In a recent Hayes Management Consulting blog, Leala M. Williams explains if Biometric identification is the answer to patient data integrity issues. Long gone are the days of standalone demographic ...

Fraud and misconduct continue apace in Alzheimer's research, undermining progress in understanding and treating the disease, say investigators who endeavor to expose errors and misleading practices.